Bioxytran (BIXT) Net Cash Flow (2010 - 2026)
Bioxytran's Net Cash Flow was -$285,663 in Q2 2026, compared with -$1,204 a year earlier.
Powered by 
Analysis
Bioxytran (BIXT) Net Cash Flow (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Bioxytran's Net Cash Flow was $174,240 through Jun 30, 2026; for FY2025, it came in at $504,760.
- In earlier years, Net Cash Flow was -$20,932 in FY2024, -$269,315 in FY2023, $223,043 in FY2022 (+627.2%) and $30,670 in FY2021.
- The Q2 2026 figure marks the lowest quarterly Net Cash Flow in data going back to Q3 2010.
- Per Business Quant data, BIXT's Net Cash Flow in the three quarters before Q2 2026 was -$46,867 (Q1 2026), $495,415 (Q4 2025) and $11,355 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | -1.27 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -2.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 1.53 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 757.00 Mn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 1.62 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.95 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -4.43 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -722.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 652.90 Mn |
| 10 | Bioxytran | 2.29 Mn | 1.13 Mn | - | -285,663.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -285,663.00 |
| Mar 31, 2026 | -46,867.00 |
| Dec 31, 2025 | 495,415.00 |
| Sep 30, 2025 | 11,355.00 |
| Jun 30, 2025 | -1,204.00 |
| Mar 31, 2025 | -806.00 |
| Dec 31, 2024 | -29,518.00 |
| Sep 30, 2024 | 21,150.00 |
| Jun 30, 2024 | 3,498.00 |
| Mar 31, 2024 | -16,062.00 |
| Dec 31, 2023 | -54,187.00 |
| Sep 30, 2023 | 35,092.00 |
| Jun 30, 2023 | -108,620.00 |
| Mar 31, 2023 | -141,600.00 |
| Dec 31, 2022 | -78,789.00 |
| Sep 30, 2022 | -126,487.00 |
| Jun 30, 2022 | -238,907.00 |
| Mar 31, 2022 | 667,226.00 |
| Dec 31, 2021 | -171,636.00 |
| Sep 30, 2021 | -144,049.00 |
API Access
Bioxytran Net Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-cash-flow&ticker=BIXT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-cash-flow", "ticker": "BIXT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-cash-flow&ticker=BIXT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();